 Pulmonary hypertension polymorphonuclear leukocyte elastase esophageal cancer operations role polymorphonuclear leukocyte PMN elastase pulmonary impairment operation esophageal cancer patients equal groups group placebo infusion infusion PMN elastase inhibitor ulinastatin placebo group mean plasma PMN elastase level micrograms/L micrograms/L hours mean plasma fibronectin concentration micrograms/mL micrograms/L postoperative day mean pulmonary vascular resistance hours group units hours start operation mean PMN elastase value hours micrograms/L fibronectin level postoperative days pulmonary vascular resistance day results PMN elastase development postoperative pulmonary impairment